Dr. Kah Fei Wan, PhD

Head of Antibody Technology at Experimental Drug Development Centre

Speaker

A pharmaceutical professional with 15 years of drug discovery experience across both public and private sectors. Possesses extensive technical, operational, and managerial expertise in translational research and project leadership for both small and large molecules. Leads a multi-functional team of scientists and engineers in high-throughput lead discovery, antibody and protein-based engineering, with a focus on oncology, immuno-oncology, ophthalmology, and infectious diseases. Proven track record in successfully out-licensing innovative biologics, securing a deal exceeding €100 million with a multinational pharmaceutical company. Key pipeline contributions include advancing a small molecule and an ADC into Phase 1 clinical trials, along with four lead candidates progressing into preclinical development. Demonstrates strong scientific and business acumen in evaluating asset licensing opportunities and fostering collaborations through public-private partnerships.